Evaluation of Drug Eluting Balloon for the Prevention of Hemodialysis Access Restenosis: A Prospective Randomized Trial (DEB Study)

Next Previous
Trial Profile

Evaluation of Drug Eluting Balloon for the Prevention of Hemodialysis Access Restenosis: A Prospective Randomized Trial (DEB Study)

Recruiting
Phase of Trial: Phase II

Latest Information Update: 19 Sep 2016

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Vascular restenosis
  • Focus Therapeutic Use

    • Most Recent Events

    • 06 Sep 2016 Planned End Date changed from 1 Mar 2016 to 1 Dec 2018.
    • 06 Sep 2016 Planned primary completion date changed from 1 Oct 2015 to 1 Aug 2018.
    • 06 Sep 2016 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top